169 related articles for article (PubMed ID: 15784544)
1. Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
Denison AM; Clapper B; Dybvig K
Infect Immun; 2005 Apr; 73(4):2033-9. PubMed ID: 15784544
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma polysaccharide protects against complement.
Bolland JR; Simmons WL; Daubenspeck JM; Dybvig K
Microbiology (Reading); 2012 Jul; 158(Pt 7):1867-1873. PubMed ID: 22504437
[TBL] [Abstract][Full Text] [Related]
3. Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.
Bolland JR; Dybvig K
FEMS Microbiol Lett; 2012 Jun; 331(1):25-30. PubMed ID: 22428866
[TBL] [Abstract][Full Text] [Related]
4. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.
Shaw BM; Daubenspeck JM; Simmons WL; Dybvig K
FEMS Microbiol Lett; 2013 Jan; 338(2):155-60. PubMed ID: 23190331
[TBL] [Abstract][Full Text] [Related]
5. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.
Simmons WL; Dybvig K
Infect Immun; 2007 Aug; 75(8):3696-9. PubMed ID: 17517864
[TBL] [Abstract][Full Text] [Related]
6. Gene rearrangements in the vsa locus of Mycoplasma pulmonis.
Shen X; Gumulak J; Yu H; French CT; Zou N; Dybvig K
J Bacteriol; 2000 May; 182(10):2900-8. PubMed ID: 10781561
[TBL] [Abstract][Full Text] [Related]
7. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.
Simmons WL; Denison AM; Dybvig K
Infect Immun; 2004 Dec; 72(12):6846-51. PubMed ID: 15557605
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
Mize MT; Sun XL; Simecka JW
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
[TBL] [Abstract][Full Text] [Related]
9. The Vsa shield of Mycoplasma pulmonis is antiphagocytic.
Shaw BM; Simmons WL; Dybvig K
Infect Immun; 2012 Feb; 80(2):704-9. PubMed ID: 22083715
[TBL] [Abstract][Full Text] [Related]
10. Profiling of cellular immune responses to Mycoplasma pulmonis infection in C57BL/6 and DBA/2 mice.
Boonyarattanasoonthorn T; Elewa YHA; Tag-El-Din-Hassan HT; Morimatsu M; Agui T
Infect Genet Evol; 2019 Sep; 73():55-65. PubMed ID: 31026602
[TBL] [Abstract][Full Text] [Related]
11. Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.
Gumulak-Smith J; Teachman A; Tu AH; Simecka JW; Lindsey JR; Dybvig K
Mol Microbiol; 2001 May; 40(4):1037-44. PubMed ID: 11401710
[TBL] [Abstract][Full Text] [Related]
12. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.
Simmons WL; Bolland JR; Daubenspeck JM; Dybvig K
J Bacteriol; 2007 Mar; 189(5):1905-13. PubMed ID: 17142389
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.
Hickman-Davis JM; Lindsey JR; Matalon S
Infect Immun; 2001 Oct; 69(10):6401-10. PubMed ID: 11553584
[TBL] [Abstract][Full Text] [Related]
14. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.
Simmons WL; Dybvig K
Infect Immun; 2003 Oct; 71(10):5733-8. PubMed ID: 14500494
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.
Wawegama NK; Markham PF; Elso CM; Kanci A; Marenda MS; Browning GF; Brodnicki TC
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263105
[TBL] [Abstract][Full Text] [Related]
16. Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.
Chopra-Dewasthaly R; Spergser J; Zimmermann M; Citti C; Jechlinger W; Rosengarten R
PLoS Pathog; 2017 Sep; 13(9):e1006656. PubMed ID: 28957426
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.
Bhugra B; Voelker LL; Zou N; Yu H; Dybvig K
Mol Microbiol; 1995 Nov; 18(4):703-14. PubMed ID: 8817492
[TBL] [Abstract][Full Text] [Related]
18. General N-and O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of Exogenous Oligosaccharide.
Daubenspeck JM; Jordan DS; Simmons W; Renfrow MB; Dybvig K
PLoS One; 2015; 10(11):e0143362. PubMed ID: 26599081
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.
Hickman-Davis J; Gibbs-Erwin J; Lindsey JR; Matalon S
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4953-8. PubMed ID: 10220400
[TBL] [Abstract][Full Text] [Related]
20. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
Cartner SC; Simecka JW; Lindsey JR; Cassell GH; Davis JK
Infect Immun; 1995 Oct; 63(10):4138-42. PubMed ID: 7558330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
